Literature DB >> 3005632

Expression of 100,000-Mr simian virus 40 (SV40) tumor antigen in mouse fibroblasts transfected with replication-defective SV40 genomes.

M F Verderame, R Pollack.   

Abstract

Simian virus 40 early region mutants which are partially or completely replication defective were tested for their ability to transform postcrisis mouse fibroblasts. All mutants tested were capable of generating anchorage-independent transformants. We have previously reported the presence of a variant tumor antigen of 100,000 Mr (100K protein) generated upon transformation by wild-type simian virus 40 virions which correlates with anchorage-independent growth (Chen et al., Mol. Cell. Biol. 1:994-1006, 1981). In this study, none of the mutants tested produced the 100K variant protein at early (before the fifth) passage. Long-term passage (greater than 20 weeks) permitted the expression of this 100K variant in half of the transformants. Thus the phenotype of these mutants is different from both wild-type simian virus 40 (frequently production of 100K by the third passage, and always by the tenth passage) and the origin-minus class of mutants (no production of 100K at any passage).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005632      PMCID: PMC252815     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Autoregulation of simian virus 40 gene A by T antigen.

Authors:  S I Reed; G R Stark; J C Alwine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  SV40 early mutants that are defective for viral DNA synthesis but competent for transformation of cultured rat and simian cells.

Authors:  Y Gluzman; B Ahrens
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

4.  Mutant of simian virus 40 large T-antigen that is defective for viral DNA synthesis, but competent for transformation of cultured rat cells.

Authors:  J R Stringer
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Simian virus 40 T-antigen: identification of tryptic peptides in the C-terminal region and definition of the reading frame.

Authors:  D T Denhardt; L V Crawford
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

6.  Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants.

Authors:  M M Manos; Y Gluzman
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

7.  Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells.

Authors:  M Verderame; D Alcorta; M Egnor; K Smith; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen.

Authors:  C Prives; E Gilboa; M Revel; E Winocour
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Nonlytic simian virus 40-specific 100K phosphoprotein is associated with anchorage-independent growth in simian virus 40-transformed and revertant mouse cell lines.

Authors:  S Chen; M Verderame; A Lo; R Pollack
Journal:  Mol Cell Biol       Date:  1981-11       Impact factor: 4.272

10.  Identification of simian virus 40 protein A.

Authors:  K Rundell; J K Collins; P Tegtmeyer; H L Ozer; C J Lai; D Nathans
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

View more
  2 in total

1.  A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.

Authors:  M F Verderame; J M Kaplan; H E Varmus
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Resolution of a polyomavirus-mouse hybrid replicon: viral function required for recombination.

Authors:  A Piché; P Bourgaux
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.